QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mymryk, J S Articles by Archer, T K Search for Related Content PubMed PubMed Citation Articles by Mymryk, J S Articles by Archer, T K Social Bookmarking                   What's this?

Research Papers

Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo.

Department of Obstetrics and Gynaecology, University of Western Ontario, London, Canada.

Abstract

We have investigated whether constitutive binding by the progesterone receptor (PR) to a promoter is required for the maintenance of an open chromatin structure in vivo. For these experiments, we used human T47D breast cancer cells in which the mouse mammary tumor virus (MMTV) promoter, stably assembled as chromatin, is constitutively hypersensitive to endonucleolytic cleavage. In vivo footprinting revealed that transcription factors nuclear factor 1 and the PR were constitutively bound to the MMTV promoter in these cells. Treatment of these cells for 1 hr with the steroid antagonist ZK98299 prevented PR binding to chromatin in vivo and reversed hypersensitivity, leading to the loss of transcription factor binding. The reduction in hypersensitivity induced by ZK98299 was readily reversed by treatment with the progestin R5020. The chromatin organization of the promoter could be cycled between the open and closed states by consecutive treatments with agonist or antagonist. The antagonist RU486 also blocked activation of transcription and the assembly of a transcription preinitiation complex, but in contrast to ZK98299, maintained the hypersensitive chromatin state. Taken together, these results suggest that PR binding to chromatin is sufficient to induce hypersensitivity to endonucleolytic cleavage. Furthermore, they indicate that the PR binding to DNA and the resulting chromatin hypersensitivity is functionally separate from transcriptional activation in vivo.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. I. Klokk, P. Kurys, C. Elbi, A. K. Nagaich, A. Hendarwanto, T. Slagsvold, C.-Y. Chang, G. L. Hager, and F. Saatcioglu Ligand-Specific Dynamics of the Androgen Receptor at Its Response Element in Living Cells Mol. Cell. Biol., March 1, 2007; 27(5): 1823 - 1843. [Abstract] [Full Text] [PDF]

				G. V. Rayasam, C. Elbi, D. A. Walker, R. Wolford, T. M. Fletcher, D. P. Edwards, and G. L. Hager Ligand-Specific Dynamics of the Progesterone Receptor in Living Cells and during Chromatin Remodeling In Vitro Mol. Cell. Biol., March 15, 2005; 25(6): 2406 - 2418. [Abstract] [Full Text] [PDF]

				P. B. Hebbar and T. K. Archer Nuclear Factor 1 Is Required for Both Hormone-Dependent Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Mol. Cell. Biol., February 1, 2003; 23(3): 887 - 898. [Abstract] [Full Text]

				E. D. Martinez and M. Danielsen Loss of Androgen Receptor Transcriptional Activity at the G1/S Transition J. Biol. Chem., August 9, 2002; 277(33): 29719 - 29729. [Abstract] [Full Text] [PDF]

				C. L. Smith, R. G. Wolford, T. B. O’Neill, and G. L. Hager Characterization of Transiently and Constitutively Expressed Progesterone Receptors: Evidence for Two Functional States Mol. Endocrinol., July 1, 2000; 14(7): 956 - 971. [Abstract] [Full Text]

				J. C. McDowell and A. Dean Structural and Functional Cross-Talk between a Distant Enhancer and the varepsilon -Globin Gene Promoter Shows Interdependence of the Two Elements in Chromatin Mol. Cell. Biol., November 1, 1999; 19(11): 7600 - 7609. [Abstract] [Full Text] [PDF]

				R. E. Kingston and G. J. Narlikar ATP-dependent remodeling and acetylation as regulators of chromatin fluidity Genes & Dev., September 15, 1999; 13(18): 2339 - 2352. [Full Text]

				Z. Liu, J. Wong, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin PNAS, August 17, 1999; 96(17): 9485 - 9490. [Abstract] [Full Text] [PDF]

				N. J. McKenna, R. B. Lanz, and B. W. O’Malley Nuclear Receptor Coregulators: Cellular and Molecular Biology Endocr. Rev., June 1, 1999; 20(3): 321 - 344. [Abstract] [Full Text]

				W. P. Bocchinfuso, W. P. Hively, J. F. Couse, H. E. Varmus, and K. S. Korach A Mouse Mammary Tumor Virus-Wnt-1 Transgene Induces Mammary Gland Hyperplasia and Tumorigenesis in Mice Lacking Estrogen Receptor-{{alpha}} Cancer Res., April 1, 1999; 59(8): 1869 - 1876. [Abstract] [Full Text] [PDF]

				H. Htun, L. T. Holth, D. Walker, J. R. Davie, and G. L. Hager Direct Visualization of the Human Estrogen Receptor alpha  Reveals a Role for Ligand in the Nuclear Distribution of the Receptor Mol. Biol. Cell, February 1, 1999; 10(2): 471 - 486. [Abstract] [Full Text]

				W. L. Kraus and J. T. Kadonaga p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation Genes & Dev., February 1, 1998; 12(3): 331 - 342. [Abstract] [Full Text]

				P. L. Sheridan, T. P. Mayall, E. Verdin, and K. A. Jones Histone acetyltransferases regulate HIV-1 enhancer activity in vitro Genes & Dev., December 15, 1997; 11(24): 3327 - 3340. [Abstract] [Full Text] [PDF]

				S. A. Brown and R. E. Kingston Disruption of downstream chromatin directed by a transcriptional activator Genes & Dev., December 1, 1997; 11(23): 3116 - 3121. [Abstract] [Full Text] [PDF]

				W. Magis, S. Fiering, M. Groudine, and D. I. K. Martin An upstream activator of transcription coordinately increases the level and epigenetic stability of gene expression PNAS, November 26, 1996; 93(24): 13914 - 13918. [Abstract] [Full Text] [PDF]

				M J Pazin, P L Sheridan, K Cannon, Z Cao, J G Keck, J T Kadonaga, and K A Jones NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes & Dev., January 1, 1996; 10(1): 37 - 49. [Abstract] [PDF]

				J Wong, Y B Shi, and A P Wolffe A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor. Genes & Dev., November 1, 1995; 9(21): 2696 - 2711. [Abstract] [PDF]

				L.-N. Song, B. Huse, S. Rusconi, and S. S. Simons Jr. Transactivation Specificity of Glucocorticoid Versus Progesterone Receptors. ROLE OF FUNCTIONALLY DIFFERENT INTERACTIONS OF TRANSCRIPTION FACTORS WITH AMINO- AND CARBOXYL-TERMINAL RECEPTOR DOMAINS J. Biol. Chem., June 29, 2001; 276(27): 24806 - 24816. [Abstract] [Full Text] [PDF]

				C. J. Fryer, H. K. Kinyamu, I. Rogatsky, M. J. Garabedian, and T. K. Archer Selective Activation of the Glucocorticoid Receptor by Steroid Antagonists in Human Breast Cancer and Osteosarcoma Cells J. Biol. Chem., June 2, 2000; 275(23): 17771 - 17777. [Abstract] [Full Text] [PDF]